Apixaban
6 NDCs across 1 manufacturer|0 Generic,6 Brand
Apixaban is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 28, 2012, and the first generic was approved Dec 23, 2019. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $20.8 billion on Apixaban across 24.1 million claims for 4.4 million beneficiaries.
Apixaban is available as 6 NDCs from 1 manufacturer (0 generic, 6 brand), with NADAC prices from $5.51 to $5.52 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
0G / 6B
Manufacturers
1
competing in market
Price Spread
$5.51 – $5.52
per EA
7d Activity
avg +0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing APIXABAN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ELIQUIS 5 MG TABLET | $5.5211 per EA | -0.03% |
ELIQUIS 5 MG TABLET | $5.5211 per EA | -0.03% |
ELIQUIS 5 MG TABLET | $5.5211 per EA | -0.03% |
ELIQUIS 2.5 MG TABLET | $5.5186 per EA | +0.07% |
ELIQUIS 2.5 MG TABLET | $5.5186 per EA | +0.07% |
ELIQUIS DVT-PE TREATMENT 30-DAY STARTER 5 MG PACK | $5.5061 per EA | 0.00% |
Frequently Asked Questions
What is Apixaban used to treat?
Apixaban is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
When did Apixaban become available as a generic?
FDA approved the first generic Apixaban (ANDA) on Dec 23, 2019. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Apixaban?
In 2024, Medicare Part D spent $20.8 billion on Apixaban across 24.1 million claims for 4.4 million beneficiaries.
How many Apixaban products are on the market?
The Apixaban drug market contains 6 NDCs from 1 manufacturer — 0 generic and 6 brand products.
What is the price range for Apixaban?
NADAC reference prices for Apixaban range from $5.5061 to $5.5211 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Apixaban?
1 manufacturer lists Apixaban in NADAC. Ranked by number of NDCs, the largest are E.R. Squibb & Sons, L.L.C. (6).
How has the price of Apixaban changed recently?
Over the past 7 days, 2 Apixaban NDCs rose and 3 fell, with a market-wide average change of +0.0%.